Columbianadin ameliorates experimental acute reflux esophagitis in rats via suppression of NF-κB pathway.
Ying WuAlthaf Hussain ShaikMinghai LuoPublished in: Acta cirurgica brasileira (2024)
Columbianadin demonstrated a protective effect against acute reflux esophagitis via NF-κB pathway.